Saturday, Dec 20th
Last update10:11:42 AM GMT
An experimental therapy using human embryonic stem cells to treat degenerative eye diseases has proved safe and effective in animal studies, and may begin early human trials in the next few months if it receives approval from the Food and Drug Administration. If granted approval, the therapy will be the second embryonic-stem-cell-based treatment to progress to human trials, and it will provide a test case for further applications of stem cells.
Dr. Kade Goepferd watched the Trump administration's moves on Thursday to ban gender-affirming care for transgender... |
 A California jury on Friday awarded $40m to two women who said Johnson & Johnson’s baby... | ||
 With subsidies for Affordable Care Act (ACA) health insurance set to expire, Americans who rely on... |
 Connecticut, Georgia, Idaho, Massachusetts, Michigan, Rhode Island, South Carolina, Texas and Puerto Rico also saw an... |
